default author photo

Antonio Bertoletti

Duke-NUS Medical School - Program in Emerging Infectious Diseases

8 College Road

Singapore

  • Duke-NUS Medical School - Program in Emerging Infectious Diseases

SCHOLARLY PAPERS

4

DOWNLOADS

251

TOTAL CITATIONS

9

Scholarly Papers (4)

Actions:
Email selected abstracts
1.

Hepatitis Delta Virus Infection Increases the Efficacy of HBV-Specific T Cell-Based Therapies

Number of pages: 48 Posted: 04 Mar 2020
Christine Y.L Tham, Anthony T. Tan, Janine Kah, Adeline Chia, Tassilo Volz, Katja Giersch, Yvonne Ladiges, Alessandro Loglio, Marta Borghi, Camille Sureau, Pietro Lampertico, Marc Lütgehetmann, Maura Dandri and Antonio Bertoletti
National University of Singapore (NUS) - Program in Emerging Infectious Diseases, National University of Singapore (NUS) - Program in Emerging Infectious Diseases, University of Hamburg - Center for Internal Medicine, National University of Singapore (NUS) - Program in Emerging Infectious Diseases, University of Hamburg - Center for Internal Medicine, University of Hamburg - Center for Internal Medicine, University of Hamburg - Center for Internal Medicine, Università degli Studi di Milano - Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Università degli Studi di Milano - Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Institut National de Transufusion Sanguine (INTS), Università degli Studi di Milano - Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, University of Hamburg - Institute of Microbiology, Virology and Hygiene, University of Hamburg - Center for Internal Medicine and Duke-NUS Medical School - Program in Emerging Infectious Diseases
Downloads 104 (669,616)

Abstract:

Loading...

Viral Hepatitis, Chronic liver disease, Immunotherapy CAR-T cell therapy

2.

Differential Effects of the Second SARS-CoV-2 mRNA Vaccine Dose on T Cell Immunity in Naïve and COVID-19 Recovered Individuals

Number of pages: 13 Posted: 12 May 2021
Daniel Lozano-Ojalvo, Carmen Camara, Eduardo Lopez-Granados, Pilar Nozal, Lucía del Pino-Molina, Yadira Bravo-Gallego, Estela Paz-Artal, Marjorie Pion, Rafael Correa-Rocha, Alberto Ortiz, Marcos Lopez-Hoyos, Marta Erro Iribarren, Jose Portoles, Maria Pilar Rojo-Portoles, Gloria Ojeda, Isabel Cervera, Maria Gonzalez-Perez, Irene Bodega-Mayor, Maria Montes-Casado, Pilar Portoles, Mayte Pérez-Olmeda, Jesús Oteo, Rodrigo Sanchez-Tarjuelo, Venu Pothula, Megan Schwarz, Manisha Brahmachary, Anthony Tanoto Tan, Nina Le Bert, Cecilia Berin, Antonio Bertoletti, Ernesto Guccione and Jordi Ochando
Icahn School of Medicine at Mount Sinai - Precision Immunology Institute, Hospital La Paz - Department of Immunology, Hospital La Paz - Department of Immunology, Hospital La Paz - Department of Immunology, Hospital La Paz - Department of Immunology, Hospital La Paz - Department of Immunology, University Hospital 12 de Octubre - Department of Immunology, Investigación Sanitaria Gregorio Marañón - Laboratory of Immune-Regulation, Investigación Sanitaria Gregorio Marañón - Laboratory of Immune-Regulation, IIS-Fundación Jiménez Díaz - Department of Nephrology, Hospital Universitario Marqués de Valdecilla-IDIVAL - Department of Immunology, Hospital Puerta de Hierro - Department of Pneumology, Hospital Puerta de Hierro - Department of Nephrology, Centro de Salud, Esquivias, Carlos III Institute of Health - National Centre for Microbiology, Carlos III Institute of Health - National Centre for Microbiology, Carlos III Institute of Health - National Centre for Microbiology, Carlos III Institute of Health - National Centre for Microbiology, Carlos III Institute of Health - National Centre for Microbiology, Carlos III Institute of Health - National Centre for Microbiology, Carlos III Institute of Health - National Centre for Microbiology, Carlos III Institute of Health - National Centre for Microbiology, Carlos III Institute of Health - National Centre for Microbiology, Icahn School of Medicine at Mount Sinai - Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai - Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai - Department of Oncological Sciences, Duke-NUS Medical School - Programme in Emerging Infectious Diseases, Duke-NUS Medical School - Program in Emerging Infectious Diseases, Icahn School of Medicine at Mount Sinai - Department of Pediatrics, Duke-NUS Medical School - Program in Emerging Infectious Diseases, Icahn School of Medicine at Mount Sinai - Department of Oncological Sciences and Icahn School of Medicine at Mount Sinai - Precision Immunology Institute
Downloads 67 (899,324)
Citation 2

Abstract:

Loading...

3.

Early T Cell and Binding Antibody Responses are Associated with COVID-19 RNA Vaccine Efficacy Onset

Number of pages: 23 Posted: 02 Mar 2021
Shirin Kalimuddin, Christine YL Tham, Martin Qui, Ruklanthi de Alwis, Jean XY Sim, Joey ME Lim, Hwee-Cheng Tan, Ayesa Syenina, Summer L. Zhang, Nina Le Bert, Anthony T. Tan, Yan Shan Leong, Jia Xin Yee, Eugenia Z. Ong, Eng Eong Ooi, Antonio Bertoletti and Jenny G. Low
National University of Singapore (NUS) - Department of Infectious Diseases, Duke-NUS Medical School - Program in Emerging Infectious Diseases, Duke-NUS Medical School - Program in Emerging Infectious Diseases, National University of Singapore (NUS) - Centre for Outbreak Preparedness, National University of Singapore (NUS) - Department of Infection Prevention and Epidemiology, Duke-NUS Medical School - Program in Emerging Infectious Diseases, Duke-NUS Medical School - Programme in Emerging Infectious Diseases, Duke-NUS Medical School - Program in Emerging Infectious Diseases, Duke-NUS Medical School - Program in Emerging Infectious Diseases, Duke-NUS Medical School - Program in Emerging Infectious Diseases, Duke-NUS Medical School - Program in Emerging Infectious Diseases, Duke-NUS Medical School - Program in Emerging Infectious Diseases, Duke-NUS Medical School - Program in Emerging Infectious Diseases, Duke-NUS Medical School - Program in Emerging Infectious Diseases, Duke-NUS Graduate Medical School - Programme in Emerging Infectious Diseases, Duke-NUS Medical School - Program in Emerging Infectious Diseases and National University of Singapore (NUS) - Department of Infectious Diseases
Downloads 56 (1,000,027)
Citation 5

Abstract:

Loading...

4.

Omicron Reactive Multi Protein Specific CD4 T Cells Defines Cellular Immune Response Induced by Inactivated Virus Vaccines

Number of pages: 50 Posted: 02 Jun 2022
Joey Lim, Shou Kit Hang, Smrithi Hariharaputran, Adeline Chia, Nicole Tan, Eng Sing Lee, Edwin Chng, Poh Lian Lim, Barnaby E. Young, David Chien Lye, Nina Le Bert, Antonio Bertoletti and Anthony T. Tan
National University of Singapore (NUS) - Program in Emerging Infectious Diseases, National University of Singapore (NUS) - Program in Emerging Infectious Diseases, National University of Singapore (NUS) - Program in Emerging Infectious Diseases, National University of Singapore (NUS) - Program in Emerging Infectious Diseases, National University of Singapore (NUS) - Program in Emerging Infectious Diseases, Nanyang Technological University (NTU) - Lee Kong Chian School of Medicine, affiliation not provided to SSRN, Nanyang Technological University (NTU) - Lee Kong Chian School of Medicine, National Centre for Infectious Diseases, Singapore, Nanyang Technological University (NTU) - Lee Kong Chian School of Medicine, Duke-NUS Medical School - Program in Emerging Infectious Diseases, Duke-NUS Medical School - Program in Emerging Infectious Diseases and Duke-NUS Medical School - Program in Emerging Infectious Diseases
Downloads 24 (1,399,036)
Citation 2

Abstract:

Loading...

COVID-19, inactivated vaccine, mRNA vaccine, T cell response, adaptive immune response